Derek Miller - 05 Nov 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Signature
/s/ Derek Miller
Issuer symbol
AMGN
Transactions as of
05 Nov 2023
Net transactions value
-$17,811
Form type
4
Filing time
07 Nov 2023, 20:20:07 UTC
Previous filing
09 May 2023
Next filing
08 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Tax liability $17,811 -66 -0.87% $269.86 7,533 05 Nov 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Equity Incentive Plan: 137 RSUs which will vest on 5/5/2024; 263 RSUs which will vest in one installment of 129 on 4/30/2024 and one installment of 134 on 4/30/2025; 866 RSUs which will vest in installments of 285 on 5/2/2024, 286 on 5/2/2025, and 295 on 5/2/2026; 1,101 RSUs which will vest in two installments of 363 each on 5/2/2025 and 5/2/2026, and 375 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 103 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.